PMID: 11333122May 3, 2001Paper

A population-based study of familial cutaneous melanoma

Melanoma Research
K HemminkiP Vaittinen

Abstract

We studied familial risks in cutaneous melanoma by comparing the occurrence of melanoma, or discordant cancer, in two generations, based on the Swedish Family-Cancer Database of 9.6 million individuals. Offspring were from 0 to 61 years of age. Cancers were obtained from the Swedish Cancer Registry for the years 1958 to 1996. The study was based on 30,170 cases of melanoma. Among these, 196 offspring came from families where a parent also presented with melanoma. The overall familial hazard ratio (FHR) was 2.47 when a parent had melanoma; an early age of onset increased the risk. Multiple primary melanomas in parents increased the FHR in offspring, being 2.23 for one, 9.10 for two and up to 83 for more than two melanomas in the parent. The number of affected offspring increased the risk of melanoma in the parents, from 3.05 when one was affected to 5.12 and 151 when two or three offspring were affected, respectively. Melanoma risk to a sibling with an affected proband was 3.56. Melanoma in one generation was associated with an increased occurrence of squamous cell carcinoma of the skin in the other generation. Other weaker associations were found to pancreatic, breast, testicular and nervous system cancers and non-Hodgkin lymph...Continue Reading

References

May 15, 1995·American Journal of Epidemiology·M Frisch, M Melbye
Jun 9, 1995·International Journal of Cancer. Journal International Du Cancer·A J SwerdlowP D Sasieni
Jan 17, 1995·International Journal of Cancer. Journal International Du Cancer·S A BirkelandL Frödin
Nov 2, 1994·Journal of the National Cancer Institute·D E GoldgarM H Skolnick
Oct 7, 1997·Lancet·K Hemminki, P Vaittinen
Nov 5, 1997·Human Molecular Genetics·M HarlandJ N Bishop
May 1, 1997·Cancer Causes & Control : CCC·D R EnglishC Fleming
Apr 29, 1998·American Journal of Epidemiology·F LeviG Erler
May 21, 1998·Genetic Epidemiology·K Hemminki, P Vaittinen
Jul 22, 1998·Genetic Epidemiology·J F AitkenN G Martin
Oct 1, 1998·International Journal of Cancer. Journal International Du Cancer·K HemminkiP Kyyrönen
Dec 3, 1998·Melanoma Research·C G AngJ P Dowling
Feb 6, 1999·International Journal of Cancer. Journal International Du Cancer·C WassbergT Hakulinen
Mar 10, 1999·Journal of the National Cancer Institute·J AitkenN Hayward
Mar 23, 1999·Archives of Dermatology·A D BurdenR M MacKie
Aug 5, 1999·Journal of the National Cancer Institute·UNKNOWN Breast Cancer Linkage Consortium
Aug 14, 1999·International Journal of Cancer. Journal International Du Cancer·K HemminkiP Vaittinen
Sep 25, 1999·International Journal of Cancer. Journal International Du Cancer·C WassbergU Ringborg
Oct 26, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K Hemminki, P Vaittinen
Apr 28, 2000·Epidemiology·K Hemminki, C Dong
May 18, 2000·Archives of Dermatology·K Hemminki, C Dong
Jun 22, 2000·International Journal of Cancer. Journal International Du Cancer·K Hemminki, C Dong

❮ Previous
Next ❯

Citations

Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·K Hemminki, Y Jiang
Dec 5, 2002·Clinical and Experimental Dermatology·F O Nestle
Oct 21, 2004·Neuro-oncology·Deirdre A HillPeter D Inskip
Jan 25, 2003·The Journal of Investigative Dermatology·Kari HemminkiKamila Czene
Aug 12, 2006·The Journal of Investigative Dermatology·April A LarsonLisa A Cannon-Albright
Mar 11, 2004·The Journal of Investigative Dermatology·Rajiv KumarKari Hemminki
Nov 26, 2008·Patient Education and Counseling·Ilse MestersHein de Vries
Oct 1, 2014·International Journal of Cancer. Journal International Du Cancer·Myeongjee LeeMarie Reilly
Mar 22, 2008·Journal of the European Academy of Dermatology and Venereology : JEADV·E NagoreC Guillen
Jan 26, 2010·Actas dermo-sifiliográficas·S BloethnerR Kumar
Sep 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott R FlorellSancy A Leachman
Jun 12, 2003·International Journal of Cancer. Journal International Du Cancer·Davide BrunettiGiorgio Stanta
Jun 5, 2003·British Journal of Cancer·K HemminkiK Czene
May 29, 2003·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·T DebniakJ Lubiński
Feb 6, 2003·International Journal of Cancer. Journal International Du Cancer·Kari HemminkiKamila Czene
Mar 18, 2003·International Journal of Cancer. Journal International Du Cancer·Kari HemminkiKamila Czene
Jul 29, 2003·Melanoma Research·Tadeusz DebniakJan Lubiński

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.